Fresenius Medical Care AG (FMCQF) Receivables Refunds (2016 - 2025)
Fresenius Medical Care AG has reported Receivables Refunds over the past 12 years, most recently at $146.9 million for Q4 2025.
- Quarterly results put Receivables Refunds at $146.9 million for Q4 2025, down 44.72% from a year ago — trailing twelve months through Dec 2025 was $146.9 million (down 44.72% YoY), and the annual figure for FY2025 was $146.9 million, down 44.72%.
- Receivables Refunds for Q4 2025 was $146.9 million at Fresenius Medical Care AG, down from $265.7 million in the prior quarter.
- Over the last five years, Receivables Refunds for FMCQF hit a ceiling of $265.7 million in Q4 2024 and a floor of $125.4 million in Q4 2021.
- Median Receivables Refunds over the past 5 years was $146.9 million (2025), compared with a mean of $179.4 million.
- Biggest five-year swings in Receivables Refunds: skyrocketed 44.79% in 2023 and later crashed 44.72% in 2025.
- Fresenius Medical Care AG's Receivables Refunds stood at $125.4 million in 2021, then grew by 17.01% to $146.7 million in 2022, then soared by 44.79% to $212.4 million in 2023, then grew by 25.11% to $265.7 million in 2024, then crashed by 44.72% to $146.9 million in 2025.
- The last three reported values for Receivables Refunds were $146.9 million (Q4 2025), $265.7 million (Q4 2024), and $212.4 million (Q4 2023) per Business Quant data.